Target intelligence / Profile preview

X-C motif chemokine ligand 2 (XCL2)

Target
XCL2
Molecular classification
Chemokine, Cytokine, Ligand (G protein-coupled receptor ligand), Other
01

Overview

X-C motif chemokine ligand 2 (XCL2) is a small secreted cytokine of the XC chemokine family, closely related to XCL1, and encoded on chromosome 1 in humans[1][5]. It is primarily expressed in activated T cells and functions by inducing chemotaxis of cells that express its cognate G protein-coupled receptor, XCR1[1][5][6]. Structurally, XCL2 exhibits a unique ability to interconvert between monomeric and dimeric forms: the monomer is responsible for activating XCR1, while the dimer binds glycosaminoglycans in the extracellular matrix[1][2][3]. Biologically, XCL2 contributes to immune response modulation, promoting recruitment of CD4+ and CD8+ T cells and macrophages, particularly under conditions of infection and cancer[3][4]. Despite significant structural similarity and functional overlap with XCL1, XCL2 shows subtle differences in glycosaminoglycan binding and may be regulated differently at the transcriptional level[1][4]. While XCL2 has emerged as a potential biomarker and a candidate for cancer immunotherapy, there are currently no drugs specifically approved that target XCL2[4].

Other names
Cytokine SCM-1 betaSCYC2SCM-1bC motif chemokine 2XC chemokine ligand 2Small inducible cytokine subfamily C, member 2
02

Mechanism of action

Activation of XCR1 (G protein-coupled chemokine receptor) leading to cell migration/chemotaxis

03

Biological functions

ChemotaxisImmune responseActivation of cytotoxic T cellsRecruitment of macrophages
04

Disease associations

CancerInflammationInfection
05

Safety considerations

No direct therapeutic safety concerns or challenges specifically documented for XCL2; general concerns may relate to immune modulation or cytokine effects in therapy
06

Biomarkers

May serve as a prognostic biomarker in cancer[4]May indicate immune cell infiltration in tumor microenvironments[4]

Beyond the preview

Go deeper on X-C motif chemokine ligand 2 (XCL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-C motif chemokine ligand 2 (XCL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call